Participants 97 204 5
patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors
Participants 428 540 4
patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors
Participants 550 568 3
Patients in REFLEX
Participants 1243 1279 6
480 patients received â‰¥ 1 RTX cour
